Main Article Content

Paulina Martínez-Bretón Universidad Veracruzana, Facultad de Medicina
Brandon Colonna-Aguirre Universidad Veracruzana, Facultad de Medicina
Noé Zebadúa Rodríguez Universidad Veracruzana, Facultad de Medicina
María I. Iñiguez-Luna Grupo Interdisciplinario de Investigación en Sechium edule en México, A.C.
Jorge D. Cadena-Zamudio Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias, Centro Nacional de Recursos Genéticos

Keywords

Abstract

Objective: Conduct a retrospective analysis of studies compiled in the literature on the current classification of Long-COVID.


Design/methodology/approach: A search was conducted in medical information platforms using the keywords: COVID-19, Long COVID, COVID.19 sequelae, SARS-CoV 2, prolonged COVID. Articles published in the chronological period between 2020 and 2023 in both English and Spanish were used. Inclusion criteria were a maximum of five years since publication, review articles, systematic reviews, meta-analyses or clinical practice guidelines. The exclusion criteria were that the articles exceeded the time limit, that they were opinion articles, case reports or trials.


Results: There is no homogenized definition or standardized guidelines or norms for the diagnosis of Long-COVID, the epidemiological studies are not completely corroborated and there is a great disparity between the incidence rates estimated in the different research works, same case for treatment.


Limitations on study/implications: The lack of homogeneity in the patterns of symptoms, classification and diagnosis by the literature and health officials.


Findings/conclusions: A multidisciplinary approach is required, where clinical findings, laboratory and imaging studies are integrated, to homogenize information in search of adequate and timely Long-COVID diagnoses and effective treatments for the benefit of patients.

Abstract | EARLY ACCESS 2 (Spanish) Downloads

References

Most read articles by the same author(s)